Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
16.02.24
€38.99
16.02.25
67.74%
29.08.24

Royal Bank of Canada 
16.02.24 50%
buy
Alkermes plc

Start price
Target price
Perf. (%)
€29.80
16.02.24
€36.20
16.02.25
-13.42%
30.08.24

Piper Sandler 
16.02.24 50%
buy
Ironwood Pharmaceuticals

Start price
Target price
Perf. (%)
€13.50
16.02.24
€19.49
16.02.25
-66.37%
30.08.24

Piper Sandler 
16.02.24 50%
buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
16.02.24
€38.96
16.02.25
-
30.09.21

Stifel Nicolaus 
16.02.24 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€22.60
16.02.24
€39.06
16.02.25
42.26%
09:30

Truist Financial Co. 
16.02.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€714.50
16.02.24
€883.50
16.02.25
21.41%
13:14

Morgan Stanley 
16.02.24 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€134.96
16.02.24
-
16.02.25
-11.65%
12:06

StockNews.com 
16.02.24 50%
sell
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€0.86
16.02.24
-
16.02.25
484.21%
12.04.24

StockNews.com 
16.02.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€1.50
16.02.24
-
16.02.25
100.00%
30.08.24

StockNews.com 
16.02.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€22.00
16.02.24
€74.42
16.02.25
57.27%
30.08.24

Piper Sandler 
16.02.24 50%
buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
16.02.24
€42.79
16.02.25
-
30.09.21

Needham & Company LLC 
16.02.24 50%
buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€4.86
16.02.24
€13.02
16.02.25
155.14%
23.08.24

Needham & Company LLC 
16.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
16.02.24
€47.44
16.02.25
-
29.01.24

Morgan Stanley 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
71.44%
09:30

Chardan Capital 
16.02.24 50%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€191.20
15.02.24
€204.23
15.02.25
-28.30%
09:30

KeyCorp 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€246.00
15.02.25
-21.33%
09:30

Evercore ISI 
15.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.00
15.02.24
€185.66
15.02.25
73.94%
09:30

Needham & Company LLC 
15.02.24 50%
buy
Tenet Healthcare

Start price
Target price
Perf. (%)
€83.50
15.02.24
€97.51
15.02.25
77.25%
09:59

Wells Fargo & Company 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€269.47
15.02.25
-21.33%
09:30

UBS Group AG 
15.02.24 50%
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€74.00
15.02.24
€87.34
15.02.25
-17.68%
30.08.24

UBS Group AG 
15.02.24 50%
buy
Stryker Corp.

Start price
Target price
Perf. (%)
€323.30
15.02.24
€334.58
15.02.25
1.11%
12:52

Royal Bank of Canada 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€248.57
15.02.25
-21.33%
09:30

Robert W. Baird 
15.02.24 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€227.80
15.02.24
€259.70
15.02.25
-21.33%
09:30

JPMorgan Chase & Co. 
15.02.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€44.60
15.02.24
€105.84
15.02.25
15.47%
30.08.24

Cantor Fitzgerald 
15.02.24 50%
sell
Lipocine Inc.

Start price
Target price
Perf. (%)
€3.67
15.02.24
-
15.02.25
-
09.02.24

StockNews.com 
15.02.24 50%